Insider Transactions in Q3 2021 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 02
2021
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-42.15%
|
$120,000
$20.52 P/Share
|
|
Aug 02
2021
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-11.64%
|
$100,000
$20.52 P/Share
|
|
Jul 01
2021
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.52%
|
$240,000
$24.12 P/Share
|